Inspira Technologies Oxy BHN (Inspira Technologies Oxy BHN) LT-Debt-to-Total-Asset : 0.09 (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Inspira Technologies Oxy BHN LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Inspira Technologies Oxy BHN's long-term debt to total assests ratio for the quarter that ended in Jun. 2023 was 0.09.

Inspira Technologies Oxy BHN's long-term debt to total assets ratio increased from Jun. 2022 (0.05) to Jun. 2023 (0.09). It may suggest that Inspira Technologies Oxy BHN is progressively becoming more dependent on debt to grow their business.

Inspira Technologies Oxy BHN LT-Debt-to-Total-Asset Historical Data

The historical data trend for Inspira Technologies Oxy BHN's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspira Technologies Oxy BHN LT-Debt-to-Total-Asset Chart

Inspira Technologies Oxy BHN Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.08

0.47

0.05

0.06

Inspira Technologies Oxy BHN Quarterly Data
	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial											0.06	0.05	0.08	0.09	0.06

Inspira Technologies Oxy BHN LT-Debt-to-Total-Asset Calculation

Inspira Technologies Oxy BHN's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0.588	/	9.31
	=

Inspira Technologies Oxy BHN's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

LT Debt to Total Assets (Q: Jun. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2023 )	/	Total Assets (Q: Jun. 2023 )
	=	1.02	/	10.84
	=

Inspira Technologies Oxy BHN (NAS:IINNW) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Inspira Technologies Oxy BHN LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Inspira Technologies Oxy BHN's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Inspira Technologies Oxy BHN (Inspira Technologies Oxy BHN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspira Technologies Oxy BHN Ltd (NAS:IINNW) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

IINN:USA

Address

2 Ha-Tidhar Street, Ra'anana, ISR, 4366504

Website

http://www.inspira-technologies.com

Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.